Goserelin

Results: 11



#Item
1Microsoft Word - DSU Degarelix FINAL sent to NICE

Microsoft Word - DSU Degarelix FINAL sent to NICE

Add to Reading List

Source URL: www.nicedsu.org.uk

Language: English - Date: 2015-06-17 10:44:39
2HORMONE THERAPY SIDE EFFECTS – PREVENTION AND TREATMENT Hormone therapy reduces the amount or effects of male hormone (testosterone). Prostate cancer uses the male hormone to grow. The cancer cells cannot survive if te

HORMONE THERAPY SIDE EFFECTS – PREVENTION AND TREATMENT Hormone therapy reduces the amount or effects of male hormone (testosterone). Prostate cancer uses the male hormone to grow. The cancer cells cannot survive if te

Add to Reading List

Source URL: www.prostate.com.au

Language: English - Date: 2007-01-01 20:57:21
3Vol.49, No.2 February[removed]Editorial Drug-induced Skin Reactions Yutaka Narisawa ..........................................................................................................................................

Vol.49, No.2 February[removed]Editorial Drug-induced Skin Reactions Yutaka Narisawa ..........................................................................................................................................

Add to Reading List

Source URL: www.med.or.jp

Language: English - Date: 2009-08-03 20:57:42
4[removed]HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ZOLADEX safely and effectively. See full prescribing information for ZOLADEX. ZOLADEX® (goserelin acetate

[removed]HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ZOLADEX safely and effectively. See full prescribing information for ZOLADEX. ZOLADEX® (goserelin acetate

Add to Reading List

Source URL: www1.astrazeneca-us.com

Language: English - Date: 2013-08-05 20:44:27
5HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ZOLADEX safely and effectively. See full prescribing information for ZOLADEX. ZOLADEX® (goserelin acetate implant)

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ZOLADEX safely and effectively. See full prescribing information for ZOLADEX. ZOLADEX® (goserelin acetate implant)

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2014-10-08 15:09:50
66-01-b EMA[removed]Final PhVWP report to CMDh- Gonadotropin-releasing hormone agonists

6-01-b EMA[removed]Final PhVWP report to CMDh- Gonadotropin-releasing hormone agonists

Add to Reading List

Source URL: www.hma.eu

Language: English - Date: 2012-03-23 07:50:16
7v HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use CASODEX® safely and effectively. See full prescribing information for CASODEX. CASODEX® (bicalutamide) Tablet fo

v HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use CASODEX® safely and effectively. See full prescribing information for CASODEX. CASODEX® (bicalutamide) Tablet fo

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2009-03-31 14:50:54
8HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use CASODEX® safely and effectively. See full prescribing information for CASODEX. CASODEX® (bicalutamide) Tablet for

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use CASODEX® safely and effectively. See full prescribing information for CASODEX. CASODEX® (bicalutamide) Tablet for

Add to Reading List

Source URL: www.fda.gov

Language: English
9NDA[removed]S-054  Zoladex (goserelin acetate implant) 3.6 mg

NDA[removed]S-054 Zoladex (goserelin acetate implant) 3.6 mg

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2011-01-20 14:36:45
10Vantas™ (histrelin implant) DESCRIPTION Vantas™ (histrelin implant) is a sterile non-biodegradable, diffusion-controlled reservoir drug delivery system designed to deliver histrelin continuously for 12 months upon su

Vantas™ (histrelin implant) DESCRIPTION Vantas™ (histrelin implant) is a sterile non-biodegradable, diffusion-controlled reservoir drug delivery system designed to deliver histrelin continuously for 12 months upon su

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2011-01-20 15:41:22